Results 111 to 120 of about 21,745 (180)

Recurrent coronary artery in-stent restenosis caused by metal allergy: a case report. [PDF]

Front Cardiovasc Med
Li Y, Dong Z, Dai Q, Feng Y, Chen L, Ma G.   +5 more
europepmc   +1 more source

The Prognostic Value of Different Patterns of Neoatherosclerosis and Treatment Modality in Patients With Coronary In-Stent Restenosis. [PDF]

Cardiovasc Ther
Shen Y, Gu N, Liu Z, Zhang W, Shen C, Wang X, Deng C, Xia Q, Zhao Y, Shi B.   +9 more
europepmc   +1 more source

Clinical efficacy of drug-eluting stents in the treatment of vertebral artery stenosis and analysis of factors contributing to stent restenosis. [PDF]

Front Neurol
Wei X, Ma Z, Wu H, Jiang H, Lan W, Xu L, Du M, Cao H, Wang X, Qiu F.   +9 more
europepmc   +1 more source

Construction and validation of a prediction model for in-stent restenosis following coronary stent implantation during dual antiplatelet therapy. [PDF]

Front Cardiovasc Med
Zhang Z, Huang Y, Ye Y, Wang Z.
europepmc   +1 more source

Association between antiphospholipid antibodies, rheumatic-immune inflammation, and coronary in-stent restenosis. [PDF]

Front Cardiovasc Med
Mao W, Wu Z, Wei Y, Wang G, Xiong T, Chang P, Ye F.   +6 more
europepmc   +1 more source

Intravascular brachytherapy vs. drug-coated balloons for in-stent restenosis in patients with diabetes. [PDF]

Front Cardiovasc Med
Sella G, Gandelman G, Blatt A, George J, Abu Khadija H, Ayyad O, Olek D, Teh BS, Lin YY, Deva A, Kharsa C, Kritya M, Anwaar MF, Elias J, El Hajj E, Raizner AE, Farach A, Kleiman NS, Shah A.   +18 more
europepmc   +1 more source

Head-to-head comparison of limus- versus paclitaxel-coated balloons in the treatment of in-stent restenosis: a meta-analysis. [PDF]

AsiaIntervention
Sagris M, Soulaidopoulos S, Ktenopoulos N, Papanikolaou A, Dimitriadis K, Patsourakos N, Tousoulis D, Scheller B, Colombo A, Tsioufis K.   +9 more
europepmc   +1 more source

Retrospective Analysis of In-Stent Restenosis in Diabetic Patients. [PDF]

Cureus
Khalid H, Mudassar H, Husnain A, Hayat MF, Baig BJ, Nazir A, Riaz H.   +6 more
europepmc   +1 more source

Remnant Cholesterol as a Predictor of Target-Vessel Failure in Patients With In-Stent Restenosis. [PDF]

Rev Cardiovasc Med
Kong XH, Lv ZH, Wang YF, Sun YD, Xu T, You W, Meng PN, Wu XQ, Wu ZM, Jia HB, Ye F.   +10 more
europepmc   +1 more source

The impact of metabolic syndrome and triglyceride-glucose index on the risk of in-stent restenosis after percutaneous coronary intervention: a retrospective study. [PDF]

Front Cardiovasc Med
Han L, Chen Y, Xu L, Chen W.
europepmc   +1 more source